相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats
Sara E. Walton et al.
PSYCHOPHARMACOLOGY (2023)
Community guidelines for GPCR ligand bias: IUPHAR review 32
Peter Kolb et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS)
Sara E. Walton et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2022)
Contribution of the caudal medullary raphe to opioid induced respiratory depression
Barbara Palkovic et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2022)
Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose
Diane P. Calello et al.
CLINICAL TOXICOLOGY (2022)
Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study
Chelsea L. Shover et al.
JOURNAL OF ADDICTION MEDICINE (2021)
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic
Joseph Friedman et al.
JAMA PSYCHIATRY (2021)
Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of Nitazene 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte et al.
ACS CHEMICAL NEUROSCIENCE (2021)
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Istvan Ujvary et al.
ACS CHEMICAL NEUROSCIENCE (2021)
β-arrestin 2 germline knockout does not attenuate opioid respiratory depression
Iris Bachmutsky et al.
ELIFE (2021)
Dose-dependent Respiratory Depression by Remifentanil in the Rabbit Parabrachial Nucleus/Kolliker-Fuse Complex and Pre-Botzinger Complex
Barbara Palkovic et al.
ANESTHESIOLOGY (2021)
Pharmacological and genetic manipulations at the μ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice
Li He et al.
NEUROPSYCHOPHARMACOLOGY (2021)
A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal
Travis W. Grim et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics
Travis W. Grim et al.
BIOLOGICAL PSYCHIATRY (2020)
Morphine-induced respiratory depression is independent of β-arrestin2 signalling
Andrea Kliewer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Alex J. Krotulski et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2020)
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis et al.
SCIENCE SIGNALING (2020)
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Reid H. J. Olsen et al.
NATURE CHEMICAL BIOLOGY (2020)
In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
Marthe M. Vandeputte et al.
ARCHIVES OF TOXICOLOGY (2020)
Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
Alexander Gillis et al.
MOLECULAR PHARMACOLOGY (2020)
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
Joaquim Azevedo Neto et al.
MOLECULES (2020)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
Alexander Gillis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling
Wonjo Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The contribution of endogenous glutamatergic input in the ventral respiratory column to respiratory rhythm
Denise R. Cook-Snyder et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2019)
The G-protein-biased agents PZM21 and TRV130 are partial agonists of μ-opioid receptor-mediated signalling to ion channels
Yevgen Yudin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics
Mie Fabricius Pedersen et al.
NEUROPHARMACOLOGY (2019)
Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016
Christopher M. Jones et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization
Elke Miess et al.
SCIENCE SIGNALING (2018)
Measuring ligand efficacy at the muopioid receptor using a conformational biosensor
Kathryn E. Livingston et al.
ELIFE (2018)
Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization
Elke Miess et al.
SCIENCE SIGNALING (2018)
Allostery at opioid receptors: modulation with small molecule ligands
Kathryn E. Livingston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Assessment of Opioid Prescribing Practices Before and After Implementation of a Health System Intervention to Reduce Opioid Overprescribing
Barry R. Meisenberg et al.
JAMA NETWORK OPEN (2018)
A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation
Terry Kenakin
MOLECULAR PHARMACOLOGY (2017)
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel μ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
Neil Singla et al.
JOURNAL OF PAIN RESEARCH (2017)
Dynamic and Kinetic Elements of μ-Opioid Receptor Functional Selectivity
Abhijeet Kapoor et al.
SCIENTIFIC REPORTS (2017)
Superagonism at G protein-coupled receptors and beyond
R. Schrage et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures
Paul Chu Sin Chung et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Role of G Protein-Coupled Receptor Kinases 2 and 3 in mu-Opioid Receptor Desensitization and Internalization
Janet D. Lowe et al.
MOLECULAR PHARMACOLOGY (2015)
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines
Scott M. DeWire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Terry Kenakin et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Mu-Opioid Receptor Coupling to Gαo Plays an Important Role in Opioid Antinociception
Jennifer T. Lamberts et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Estimation of Relative Microscopic Affinity Constants of Agonists for the Active State of the Receptor in Functional Studies on M2 and M3 Muscarinic Receptors
John A. Tran et al.
MOLECULAR PHARMACOLOGY (2009)
Estimation of agonist activity at G protein-coupled receptors:: Analysis of M2 muscarinic receptor signaling through Gi/o, Gs, and G15
Michael T. Griffin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Analysis of allosterism in functional assays
FJ Ehlert
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Differential tolerance to antinociceptive effects of μ opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats
EA Walker et al.
PSYCHOPHARMACOLOGY (2001)